Whitehawk Therapeutics, Inc. (WHWK)
NASDAQ: WHWK · Real-Time Price · USD
3.590
-0.060 (-1.64%)
At close: Mar 24, 2026, 4:00 PM EDT
3.590
0.00 (0.00%)
After-hours: Mar 24, 2026, 4:25 PM EDT
Whitehawk Therapeutics Revenue
In the year 2025, Whitehawk Therapeutics had annual revenue of $7.15M, down -72.50%.
Revenue (ttm)
$7.15M
Revenue Growth
-72.50%
P/S Ratio
23.71
Revenue / Employee
$324,773
Employees
23
Market Cap
169.44M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 7.15M | -18.84M | -72.50% |
| Dec 31, 2024 | 25.98M | 1.63M | 6.69% |
| Dec 31, 2023 | 24.35M | 9.14M | 60.06% |
| Dec 31, 2022 | 15.22M | 14.10M | 1,258.57% |
| Dec 31, 2021 | 1.12M | -13.46M | -92.32% |
| Dec 31, 2020 | 14.58M | - | - |
| Dec 31, 2019 | - | - | - |
| Dec 31, 2018 | 20.16M | - | - |
| Dec 31, 2017 | - | - | - |
| Dec 31, 2016 | - | - | - |
| Dec 31, 2015 | - | - | - |
| Dec 31, 2014 | - | - | - |
| Dec 31, 2013 | - | - | - |
| Dec 31, 2012 | - | - | - |
| Dec 31, 2011 | - | - | - |
| Dec 31, 2010 | - | - | - |
| Dec 31, 2009 | - | - | - |
| Dec 31, 2008 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| MacroGenics | 149.50M |
| Protalix BioTherapeutics | 52.74M |
| Fennec Pharmaceuticals | 44.64M |
| Caribou Biosciences | 11.16M |
| Molecular Partners AG | 856.30K |
| Connect Biopharma Holdings | 762.00K |
| Adagene | 103.20K |
| NeOnc Technologies Holdings | 59.99K |
WHWK News
- 7 days ago - Whitehawk Therapeutics to Highlight its Next-Generation ADC Portfolio at the American Association for Cancer Research (AACR) Annual Meeting 2026 - PRNewsWire
- 12 days ago - Whitehawk Therapeutics Reports Fourth Quarter and Full-Year 2025 Financial Results and Recent Highlights - PRNewsWire
- 26 days ago - Whitehawk Therapeutics to Participate in Upcoming Investor Conferences - PRNewsWire
- 4 weeks ago - Whitehawk Therapeutics to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference - PRNewsWire
- 2 months ago - Whitehawk Therapeutics Advances to Clinical Stage with IND Clearance for HWK-007 and Announces IND Submission for HWK-016 - PRNewsWire
- 4 months ago - Whitehawk Therapeutics Appoints Margaret Dugan, MD, as Chief Medical Officer - PRNewsWire
- 4 months ago - Whitehawk Therapeutics to Participate in the Piper Sandler 37th Annual Healthcare Conference - PRNewsWire
- 4 months ago - Whitehawk Therapeutics to Present at Jefferies Global Healthcare Conference in London - PRNewsWire